吕万良团队在靶向性基因编辑系统抗转移性乳腺癌研究方面取得进展
北京大学药学院 天然药物及仿生药物国家重点实验室
The group of Professor Wanliang Lu has made progress in targeted gene editing systems against metastatic breast cancer
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2021, (10): 851
-852
.
>
>